Risk factors for aggravated COVID-19 despite medical care after admission among Japanese patients: A Japanese association for infectious diseases COVID registry study
Itaru Nakamura, Yusuke Koizumi, Hideki Araoka, Hiroaki Hata, Takashi Miki, Yusuke Tanaka, Chie Kobayashi, Kazuyoshi Kawakami, Rizaldy Taslim Pinzon, Fumihiro Yamaguchi, Fumihiro Yamaguchi, Fumihiro Yamaguchi

TL;DR
The study identifies risk factors for severe COVID-19 progression in Japanese patients despite hospital treatment, highlighting the need for early risk assessment.
Contribution
The study provides novel insights into risk factors for disease aggravation in Japanese patients during the Wuhan strain period.
Findings
Admission early in the pandemic, older age, and impaired consciousness were independent risk factors for disease aggravation.
Model I and Model II showed strong predictive performance with AUCs of 0.8928 and 0.8862, respectively.
Abstract
Limited data are available on COVID-19 outcomes in the Japanese population. During the Wuhan strain–dominant period, we investigated factors associated with clinical deterioration of COVID-19 despite inpatient medical care in Japan. This retrospective, multicenter cohort study used data from the Japanese Association for Infectious Diseases (JAID) COVID registry to identify risk factors for progression to severe disease after hospital admission. The study population included Japanese patients with a confirmed diagnosis of COVID-19 between January 2020 and March 2021. Baseline data included demographics, symptoms at disease onset and admission, and laboratory findings. Univariate and multivariate logistic regression models were used to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for each explanatory variable associated with disease aggravation. Multiple imputation was…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 Clinical Research Studies · Respiratory viral infections research · Long-Term Effects of COVID-19
